Ads
related to: therapy notes pricingsoftwareadvice.com has been visited by 10K+ users in the past month
- Research & Advice
The Latest Software Research
For Buyers Like You
- About Us
We Help You Find the Right Software
With a Free, Expert Consultation
- Compare Software Reviews
Learn About Software Systems
And Read User Reviews
- Buyer's Guide
Explore Common Features And
Benefits of Medical Software
- Research & Advice
Search results
Nurix Therapeutics (NASDAQ:NRIX) Trading Up 4.4% on Analyst Upgrade
ETF DAILY NEWS· 2 days agoNurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) shares were up 4.4% on Tuesday after HC Wainwright raised their price target on the stock from $19.00 to $26.00. HC ...
Iovance Biotherapeutics (NASDAQ:IOVA) Price Target Lowered to $23.00 at JMP Securities
ETF DAILY NEWS· 22 hours agoIovance Biotherapeutics (NASDAQ:IOVA – Get Free Report) had its target price lowered by research analysts at JMP Securities from $25.00 to $23.00 in a note
Zerlasiran shows promise in phase 2 study for cardiovascular risk By Investing.com
Investing.com· 16 hours agoSilence Therapeutics plc (NASDAQ:SLN), a biotech firm focusing on RNA interference (RNAi) therapies,...
Revolution Medicines executive sells over $208k in company stock By Investing.com
Investing.com· 10 hours ago(NASDAQ:RVMD) has reported a significant stock transaction by one of its top executives in a recent...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
Missouri Independent via Yahoo News· 4 days agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
90 swimming pools, 24-karat gold facials, and all-day champagne: Inside the Middle East’s ‘best’...
CNN via Yahoo News· 7 days agoBut there are more “accessible” ways to enjoy the resort, says Roelens: the Sky Blaze fountain, for...
Perspective Therapeutics (NYSE:CATX) Rating Reiterated by Oppenheimer
ETF DAILY NEWS· 1 day agoRoyal Bank of Canada reiterated an “outperform” rating and issued a $30.00 target price on shares of...
Cantor Fitzgerald Reiterates “Overweight” Rating for Perspective Therapeutics (NYSE:CATX)
ETF DAILY NEWS· 1 day agoRoyal Bank of Canada reiterated an “outperform” rating and issued a $30.00 price objective on shares...
The latest trendy skin care treatment replacing the viral ‘vampire facial’
NY Post via Yahoo News· 4 days agoThe Kim Kardashian-endorsed platelet rich plasma procedure, or PRP, is being replaced at New York...
American International Group Inc. Reduces Position in Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 3 days agoAmerican International Group Inc. trimmed its holdings in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 6.3% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned ...
Ads
related to: therapy notes pricingsoftwareadvice.com has been visited by 10K+ users in the past month